Association of sterol regulatory elementbinding transcription factor gene polymorphisms with ischaemic stroke

Journal of International Medical Research

Volumn 40, Issue 1, 2012, Pages 157-166

  Jin, X ^a   Zeng, F ^a   Zhang, N ^a   Huang, T ^a   Meng, Q ^a   Liu, Yunhai ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cerebrovascular disease; Genotype; High density lipoprotein; Ischaemic stroke; Polymorphism; Sterol regulatory element binding transcription factor

Indexed keywords

CHOLESTEROL; CYTOSINE; DNA; GUANINE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BRAIN ISCHEMIA; CASE CONTROL STUDY; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STEROL REGULATORY ELEMENT BINDING TRANSCRIPTION FACTOR GENE;

EID: 84863239420     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001204000116     Document Type: Article

References (35)

1. Goldstein LB, Adams R, Becker K, et al: Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 2001; 32: 280-299.
2. Catto AJ: Genetic aspects of the hemostatic system in cerebrovascular disease. Neurology 2001; 57(5 suppl 2): S24-S30.
3. Grau AJ, Weimar C, Buggle F, et al: Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke 2001; 32: 2559-2566.
4. Robinet P, Védie B, Chironi G, et al: Characterization of polymorphic structure of SREBP-2 gene: role in atherosclerosis. Atherosclerosis 2003; 168: 381-387.
5. Shimano H, Horton JD, Hammer RE, et al: Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Invest 1996; 98: 1575-1584.
6. Shimano H, Horton JD, Shimomura I, et al: Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest 1997; 99: 846-854.
7. Amemiya-Kudo M, Shimano H, Hasty AH, et al: Transcriptional activities of nuclear SREBP-1a,-1c, and-2 to different target promoters of lipogenic and cholesterogenic genes. J Lipid Res 2002; 43: 1220-1235.
8. Horton JD, Shimomura I, Brown MS, et al: Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J Clin Invest 1998; 101: 2331-2339.
9. Shimomura I, Shimano H, Horton JD, et al: Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J Clin Invest 1997; 99: 838-845.
10. Pai JT, Guryev O, Brown MS, et al: Differential stimulation of cholesterol and unsaturated fatty acid biosynthesis in cells expressing individual nuclear sterol regulatory elementbinding proteins. J Biol Chem 1998; 273: 26138-26148.
11. Eberlé D, Clément K, Meyre D, et al: SREBF-1 gene polymorphisms are associated with obesity and type 2 diabetes in French obese and diabetic cohorts. Diabetes 2004; 53: 2153-2157.
12. Laudes M, Barroso I, Luan J, et al: Genetic variants in human sterol regulatory element binding protein-1c in syndromes of severe insulin resistance and type 2 diabetes. Diabetes 2004; 53: 842-846.
13. Miserez AR, Muller PY, Barella L, et al: Sterolregulatory element-binding protein (SREBP)-2 contributes to polygenic hypercholesterol-aemia. Atherosclerosis 2002; 164: 15-26.
14. Felder TK, Oberkofler H, Weitgasser R, et al: The SREBF-1 locus is associated with type 2 diabetes and plasma adiponectin levels in a middleaged Austrian population. Int J Obes (Lond) 2007; 31: 1099-1103.
15. Smith LM, Fung S, Hunkapiller MW, et al: The synthesis of oligonucleotides containing an aliphatic amino group at the 5aaterminus: synthesis of fluorescent DNA primers for use in DNA sequence analysis. Nucleic Acids Res 1985; 13: 2399-2412.
16. Liu J, Cheng J, Peng J, et al: Effects of polymorphisms of heat shock protein 70 gene on ischemic stroke, and interaction with smoking in China. Clin Chim Acta 2007; 384: 64-68.
17. Gan XM, Xu YH, Liu L, et al: Predicting the incidence risk of ischemic stroke in a hospital population of southern China: a classification tree analysis. J Neurol Sci 2011; 306: 108-114.
18. Simple English Wikipedia: Han Chinese (available at: http://simple.wikipedia.org/wiki/ Han_Chinese).
19. Miserez AR, Muller PY, Barella L, et al: A singlenucleotide polymorphism in the sterolregulatory element-binding protein 1c gene is predictive of HIV-related hyperlipoprotein-aemia. AIDS 2001; 15: 2045-2049.
20. Muller PY, Miserez AR: Identification of mutation in the gene encoding sterol regulatory element binding protein (SREBP)-2 in hypercholesterolaemic subjects. J Med Genet 2002; 39: 271-275.
21. Eberlé D, Clément K, Meyre D, et al: SREBF-1 gene polymorphisms are associated with obesity and type 2 diabetes in French obese and diabetic cohorts. Diabetes 2004; 53: 2153-2157.
22. Ishigaki N, Yamamoto T, Shimizu Y, et al: Involvement of glomerular SREBP-1c in diabetic nephropathy. Biochem Biophys Res Commun 2007; 364: 502-508.
23. Grarup N, Stender-Petersen KL, Andersson EA, et al: Association of variants in the sterol regulatory element-binding factor 1 (SREBF1) gene with type 2 diabetes, glycemia, and insulin resistance: a study of 15,734 Danish subjects. Diabetes 2008; 57: 1136-1142.
24. Suk SH, Sacco RL, Boden-Albala B, et al: Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study. Stroke 2003; 34: 1586-1592.
25. Giorda CB, Avogaro A, Maggini M, et al: Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study. Stroke 2007; 38: 1154-1160.
26. Kiechl S, Egger G, Mayr M, et al: Chronic infections and risk of carotid atherosclerosis: prospective result from a large population study. Circulation 2001; 103: 1064-1070.
27. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
28. Neaton JD, Blackburn H, Jacobs D, et al: Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Arch Intern Med 1992; 152: 1490-1500.
29. Lamarche B, Tchernof A, Moorjani S, et al: Small, dense-low density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. Circulation 1997; 195: 69-75.
30. Bowman TS, Sesso HD, Ma J, et al: Cholesterol and the risk of ischemic stroke. Stroke 2003; 34: 2930-2934.
31. Barter PJ, Brandrup-Wognsen G, Palmer MK, et al: Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database. J Lipid Res 2010; 51: 1546-1553.
32. Brewer HB Jr: Clinical review: the evolving role of HDL in the treatment of high-risk patients with cardiovascular disease. J Clin Endocrinol Metab 2011; 96: 1246-1257.
33. Nordestgaard BG, Tybjærg-Hansen A: Genetic determinants of LDL, lipoprotein(a), triglyceride-rich lipoproteins and HDL: concordance and discordance with cardiovascular disease risk. Curr Opin Lipidol 2011; 22: 113-122.
34. Haas MJ, Mooradian AD: Inflammation, highdensity lipoprotein and cardiovascular dysfunction. Curr Opin Infect Dis 2011; 24: 265-272.
35. Sato R: Sterol metabolism and SREBP activation. Arch Biochem Biophys 2010; 501: 177-181.